Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
The 7 Best Dividend Stocks to Buy in February 2024
09:05am, Thursday, 15'th Feb 2024
The stock market is at record highs. And more speculative growth names such as artificial intelligence-focused technology firms are skyrocketing.
Pfizer at 10-year support: Is it a massive buy opportunity?
07:30am, Thursday, 15'th Feb 2024
For shareholders of the multinational biotech giant Pfizer Inc. NYSE: PFE, it might feel like the stock's all-time highs set during the pandemic were centuries ago. After making its COVID-19-related
7 Undervalued Dividend Stocks to Buy in February for High Total Returns
06:15am, Thursday, 15'th Feb 2024
Investors can purchase undervalued dividend stocks to form the backbone of any portfolio. I say this because these stocks are generally low-beta and represent blue-chip companies.
Biden Boom: 7 Stocks to Buy if Democrats Win the Election in 2024
09:20pm, Wednesday, 14'th Feb 2024
We've entered another election year, with President Biden likely to face off once more against former President Trump. The polls currently show a tight race, though Biden's approval ratings have slipp
Pfizer agrees to pay $93 mln to settle Lipitor antitrust lawsuit
08:28pm, Wednesday, 14'th Feb 2024
Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less expensive, generic
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
02:43pm, Wednesday, 14'th Feb 2024
It is entirely fair to state that weight loss treatments have massive transformational power. US FDA approval of weight loss medicines could help shrink millions of waistlines.
7 High-Yield Dividend Stocks for the Ultimate Retirement Portfolio
02:57pm, Tuesday, 13'th Feb 2024
Retirement planning is a vital phase of life (the climax) that demands careful strategic investment decisions. Among vast investment options, high-yield dividend stocks for retirement are ideal for st
3 Blue-Chip Stocks Drowning in Earnings Despair
01:32pm, Tuesday, 13'th Feb 2024
While overall earnings for the final quarter of 2023 have been positive, not every company is celebrating. A number of well-known concerns missed the mark with their latest prints, plummeting their sh
Pfizer Stock: It's Time To Buy The Dip
04:40pm, Monday, 12'th Feb 2024
Pfizer's depressed valuation and strong product pipeline make it the ultimate buying opportunity for income investors in the healthcare sector. Despite a decline in sales of COVID-19 drugs, Pfizer's o
A Look at Pharma ETFs After Q4 Earnings
02:01pm, Monday, 12'th Feb 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs re
2 Value Stocks With Monster Yields
09:15am, Monday, 12'th Feb 2024
Value stocks may be gearing up for a comeback in 2024. AT&T and Pfizer are two value stocks that could benefit enormously from a change in sentiment.
Pfizer Is A Great Investment Over The Next Decade; Buy
03:13am, Friday, 09'th Feb 2024
Pfizer Is A Great Investment Over The Next Decade; Buy
3 Blue-Chip Stocks to Buy for High Total Returns by 2025
01:49pm, Thursday, 08'th Feb 2024
Blue-chip stocks generally command fair valuation or trade at a premium to market valuation. The reasons include a low beta, stable cash flows and a healthy dividend yield.
Pfizer might get Alzheimer's lift from Viagra, study suggests
10:26am, Thursday, 08'th Feb 2024
Pfizer had some rare good news in a tough twelve months for the US pharma as a new study suggested that men who take Viagra for erectile dysfunction might have a reduced risk of Alzheimer's disease. R
Dividend Harvesting Portfolio Week 153: $15,300 Allocated, $1,349.21 In Projected Dividends
09:00am, Thursday, 08'th Feb 2024
Big tech earnings and the Fed meeting dominated the headlines, with the S&P 500 and Nasdaq finishing the week up. META was the winner this earnings season, with shares climbing 19.2% after a strong qu
